MINNEAPOLIS, May 10, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery and producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that it expects to secure its first European sales of the STREAMWAY® Systems in the second half of 2018. Based on the interest generated to date, and the stage of negotiations with several potential customers, the Company expects theseRead more
- Chinese bitcoin mining gear makers set sights on world’s largest bitcoin IPOs
- Las Vegas Railway Express, Inc., dba United Rail Inc., Files Reg A with SEC for $5 million Offering
- Esports Entertainment Group Announces $600,000 Financing With First Capital Ventures
- Marijuana Company of America’s Joint Venture Completes set up of 10,000 sq ft. Greenhouse
- The Most User-friendly Cryptocurrency Exchange DragonEx Accelerates Its Global Business Strategy in New York Blockchain Week
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More